Painless myocardial ischemia is associated with mortality in patients with chronic kidney disease

Nephron - Clinical Practice

Volumn 122, Issue 1-2, 2013, Pages 9-16

  Wetmore, James B ^a   Broce, Mike ^b   Malas, Amer ^c   Almehmi, Ammar ^d  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b CHARLESTON AREA MEDICAL CENTER   (United States)

^c St Francis Medical Center   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Chronic kidney disease; Coronary artery disease; Mortality; Myocardial ischemia

Indexed keywords

CREATININE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; UREA;

ADULT; AGED; ARTICLE; BALLOON DILATATION; CALCULATION; CAUSE OF DEATH; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; HYPOTHESIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SILENT MYOCARDIAL ISCHEMIA; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; UREA NITROGEN BLOOD LEVEL;

AGED; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84874629413     PISSN: None     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000347143     Document Type: Article

References (42)

1. Jaar BG, Coresh J, Plantinga LC, et al: Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005; 143: 174-183.
2. Vonesh EF, Snyder JJ, Foley RN, Collins AJ: The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004; 66: 2389-2401.
3. Pun PH, Smarz TR, Honeycutt EF, et al: Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009; 76: 652-658.
4. Herzog CA, Mangrum JM, Passman R: Sudden cardiac death and dialysis patients. Semin Dial 2008; 21: 300-307.
5. Aronow WS, Ahn C, Mercando AD, Epstein S: Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol 2000; 86: 1142-1143, A9.
6. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G: Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986; 314: 1214-1219.
7. Deedwania PC, Carbajal EV: Silent ischemia during daily life is an independent predictor of mortality in stable angina. Circulation 1990; 81: 748-756.
8. Mohi-ud-din K, Bali HK, Banerjee S, Sakhuja V, Jha V: Silent myocardial ischemia and high-grade ventricular arrhythmias in patients on maintenance hemodialysis. Ren Fail 2005; 27: 171-175.
9. Narula AS, Jha V, Bali HK, Sakhuja V, Sapru RP: Cardiac arrhythmias and silent myocardial ischemia during hemodialysis. Ren Fail 2000; 22: 355-368.
10. McIntyre CW, Burton JO, Selby NM, et al: Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 2008; 3: 19-26.
11. Dasselaar JJ, Slart RH, Knip M, et al: Haemodialysis is associated with a pronounced fall in myocardial perfusion. Nephrol Dial Transplant 2009; 24: 604-610.
12. Assa S, Hummel YM, Voors AA, et al: Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance. Clin J Am Soc Nephrol 2012; 7: 1615-1623.
13. Yamamuro M, Lytle BW, Sapp SK, et al: Risk factors and outcomes after coronary reoperation in 739 elderly patients. Ann Thorac Surg 2000; 69: 464-474.
14. Morrison DA, Sethi G, Sacks J, et al: Percutaneous coronary intervention versus coronary bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: the VA AWESOME multicenter registry: comparison with the randomized clinical trial. J Am Coll Cardiol 2002; 39: 266-273.
15. Levey AS, Bosch JP, Lewis JB, et al: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
16. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
17. Gutterman DD: Silent myocardial ischemia. Circ J 2009; 73: 785-797.
18. Cohn PF, Fox KM, Daly C: Silent myocardial ischemia. Circulation 2003; 108: 1263-1277.
19. Cleman M, Wohlgelernter D, Cabin H, et al: Myocardial dysfunction during percutaneous transluminal coronary angioplasty. Circulation 1990; 81:IV14-IV19.
20. Wohlgelernter D, Jaffe CC, Cabin HS, Yeatman LA Jr, Cleman M: Silent ischemia during coronary occlusion produced by balloon inflation: relation to regional myocardial dysfunction. J Am Coll Cardiol 1987; 10: 491-498.
21. Falcone C, Auguadro C, Sconocchia R, et al: Susceptibility to pain during coronary angioplasty: usefulness of pulpal test. J Am Coll Cardiol 1996; 28: 903-909.
22. Laukkanen JA, Kurl S, Lakka TA, et al: Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middleaged men. J Am Coll Cardiol 2001; 38: 72-79.
23. Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM: Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective. Am J Kidney Dis 2006; 47: 378-384.
24. Levin A, Thompson CR, Ethier J, et al: Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis 1999; 34: 125-134.
25. Amann K, Breitbach M, Ritz E, Mall G: Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998; 9: 1018-1022.
26. Ieda M, Fukuda K: New aspects for the treatment of cardiac diseases based on the diversity of functional controls on cardiac muscles: the regulatory mechanisms of cardiac innervation and their critical roles in cardiac performance. J Pharmacol Sci 2009; 109: 348-353.
27. Cao JM, Fishbein MC, Han JB, et al: Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000; 101: 1960-1969.
28. Carrero JJ, Stenvinkel P: Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol 2009; 4(Suppl 1):S49-S55.
29. Li JJ: Silent myocardial ischemia may be related to inflammatory response. Med Hypotheses 2004; 62: 252-256.
30. Parthenakis F, Kochiadakis G, Simantirakis E, et al: Incidence of ventricular arrhythmias during silent myocardial ischaemia in coronary artery disease. Int J Cardiol 1996; 57: 61-67.
31. Ditchburn CJ, Hall JA, de Belder M, et al: Silent myocardial ischaemia in patients with proved coronary artery disease: a comparison of diabetic and non-diabetic patients. Postgrad Med J 2001; 77: 395-398.
32. Falcone C, Nespoli L, Geroldi D, et al: Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. Int J Cardiol 2003; 90: 219-227.
33. Caracciolo EA, Chaitman BR, Forman SA, et al: Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. ACIP Investigators. Asymptomatic Cardiac Ischemia Pilot Investigators. Circulation 1996; 93: 2097-2105.
34. Wackers FJ, Young LH, Inzucchi SE, et al: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004; 27: 1954-1961.
35. Vinik AI, Maser RE, Mitchell BD, Freeman R: Diabetic autonomic neuropathy. Diabetes Care 2003; 26: 1553-1579.
36. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
37. Koehntop DE, Rodman JH: Fentanyl pharmacokinetics in patients undergoing renal transplantation. Pharmacotherapy 1997; 17: 746-752.
38. Serruys PW: Fourth annual American College of Cardiology international lecture: a journey in the interventional field. J Am Coll Cardiol 2006; 47: 1754-1768.
39. Newsome LT, Kutcher MA, Royster RL: Coronary artery stents: part I. Evolution of percutaneous coronary intervention. Anesth Analg 2008; 107: 552-569.
40. Newsome LT, Weller RS, Gerancher JC, Kutcher MA, Royster RL: Coronary artery stents: II. Perioperative considerations and management. Anesth Analg 2008; 107: 570-590.
41. Heyndrickx GR: Is functional assessment necessary in patients with stable angina? EuroIntervention 2010; 6(Suppl G):G101-G106.
42. Blankenship JC, Moussa ID, Chambers CC, et al: Staging of multivessel percutaneous coronary interventions: an expert consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 2012; 79: 1138-1152.